Inventor · disambiguated record
Tongtong Xue
Also filed as: XUE TONGTONG
12 granted patents·23 pending applications·5 citations·filing 2016–2025
82Inventor score
Files withSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD29MEDILINK THERAPEUTICS SUZHOU CO LTD2AMPSOURCE BIOPHARMA SHANGHAI INC1CHENGDU KELUN PREC BIOTECHNOLOGY CO LTD1HARBOUR BIOMED THERAPEUTICS LTD1
Top patents by PatentIndex Score
35 records- 0180US11136413B2PDL-1 antibody, pharmaceutical composition thereof, and uses thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2019·Granted Oct 5, 2021·1 cites·40 claims
- 0278US12297265B2Antibody and use thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2019·Granted May 13, 2025·1 cites·43 claims
- 0378US10465014B2PDL-1 antibody, pharmaceutical composition thereof, and uses thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2017·Granted Nov 5, 2019·1 cites·64 claims
- 0477US12258419B2Anti-FXI/FXIa antibody and use thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2020·Granted Mar 25, 2025·1 cites·27 claims
- 0577US2024382612A1Bioactive conjugate, preparation method therefor and use thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2024·Application pending·0 cites
- 0674US2023293536A1Anti-erbb2 antibody-drug conjugate and composition thereof, preparation method therefor, and application thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0773US2023357259A1Bioactive conjugate, preparation method therefor and use thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0870US11884725B2Antibody against TIM-3 and application thereofAMPSOURCE BIOPHARMA SHANGHAI INC·Filed 2019·Granted Jan 30, 2024·1 cites·20 claims
- 0970US2025340630A1Antibody and use thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2025·Application pending·0 cites
- 1066US11970506B2Bioactive molecule conjugate, preparation method and use thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2018·Granted Apr 30, 2024·0 cites·22 claims
- 1166US11903948B2Anti-ErbB2 antibody-drug conjugate and composition thereof, preparation method therefor, and use thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2021·Granted Feb 20, 2024·0 cites·7 claims
- 1261US2025332272A1Preparation method for drug linker conjugate and intermediate thereofMEDILINK THERAPEUTICS SUZHOU CO LTD·Filed 2023·Application pending·0 cites
- 1359US2025325688A1Antibody-drug conjugate containing protein degradation agent bioactive compound, method for preparing same, and use thereofMEDILINK THERAPEUTICS SUZHOU CO LTD·Filed 2023·Application pending·0 cites
- 1456US2025144229A1Conjugate of antibody-eribulin or derivative thereof, intermediate thereof, preparation method therefor, pharmaceutical composition thereof and use thereofMEDLINK THERAPEUTICS SUZHOU CO LTD·Filed 2023·Application pending·0 cites
- 1554US2022008553A1Anti-erbb2 antibody-drug conjugate and composition thereof, preparation method therefor, and use thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 1654US2025223352A2Anti-nectin-4 antibody, conjugate including the same, and application thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 1753US2023338565A1Antibody drug conjugate, preparation method therefor and use thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 1852US2023203178A1Chimeric antigen receptor car or car construct targeting bcma and cd19 and application thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 1951US2022363781A1Anti-tslp antibody and uses thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 2050US12269816B2Benzothiophene compound, preparation method therefor and use thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2020·Granted Apr 8, 2025·0 cites·29 claims
- 2150US11655295B2Anti-LAG-3 antibody and use thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2019·Granted May 23, 2023·0 cites·28 claims
- 2250US2023303562A1Pyrazole compound and preparation method therefor and use thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 2350US2023295174A1Salt and crystal form of pyrimidine compound, and preparation methods thereforSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 2449US2025269026A1Chimeric antigen receptor which specifically binds to msln, and application thereofCHENGDU KELUN PREC BIOTECHNOLOGY CO LTD·Filed 2021·Application pending·0 cites
- 2548US2023287122A1Anti-pd-l1 antibody preparationHARBOUR BIOMED THERAPEUTICS LTD·Filed 2019·Application pending·0 cites
- 2648US2019076438A1Anti-erbb2 antibody-drug conjugate and composition thereof, preparation method therefor, and application thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2016·Application pending·0 cites
- 2748US2022056043A1Nitrogen-containing fused cyclic compound, preparation method therefor and use thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 2847US11207420B2Cytotoxin and conjugate, uses of same and preparation method thereforSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2018·Granted Dec 28, 2021·0 cites·36 claims
- 2946US2024425593A1Anti-pd-1 antibody and use thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 3046US2022017483A1Aminopyridine compound, preparation method therefor and use thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2019·Application pending·0 cites
- 3145US12150944B2Use of anti-HER2 antibody-drug conjugate in cancer treatmentSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2019·Granted Nov 26, 2024·0 cites·26 claims
- 3245US2021395226A1Substituted aryl compound and preparation method therefor and use thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2019·Application pending·0 cites
- 3342US2022144847A1Heterocyclic compound, pharmaceutical composition comprising same, preparation method therefor, and use thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 3438US11421029B2Recombinant bispecific antibodies to PD-L1 and CTLA-4SICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2018·Granted Aug 23, 2022·0 cites·40 claims
- 3538US2022220075A1Solid form of aromatic compound and preparation method thereforSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →